Drug Safety & Regulation: The FDA issued four warning letters to peptide sellers, alleging they illegally market unapproved peptides as drugs—another reminder that the supplement/“research chemical” gray zone can carry real health risk. Workforce & Access: A Supreme Court move ending Haiti TPS threatens work authorization for thousands of Haitian health care workers in Florida, raising the odds of staffing gaps for nursing homes and home health aides. Public Health & Supply Chain: Drug shortages may be down overall, but hospitals still spend heavily to manage remaining shortages; compounding pharmacies are positioned as a backup, though scaling up fast strains quality systems and operations. Infectious Disease Watch: New Mexico confirmed another plague case in wildlife after a wild rat tested positive, following multiple dog cases—an early warning for pet owners and clinicians. Patient Safety: Nearly 40,000 Clear Eyes Maximum Itchy Eye Relief bottles were recalled nationwide over sterility concerns. Military Health Policy: The Pentagon expanded routine hormone-related screening, requiring testosterone testing for many men starting at age 30. Climate Health: New analysis warns extreme heat is moving toward “unlivable” conditions in parts of the U.S., with heat-index days above 105°F projected to rise sharply. Health Care Costs & Coverage: Medicare prior authorization rules are expanding, with more HCPCS codes added for October—another administrative pressure point for providers and patients.